The Patent Finder

Terms ending in 2035

2SEVENTY Bio, Inc.

Every in-force patent on 2SEVENTY Bio, Inc.'s record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 10,774,343MND Promoter Chimeric Antigen Receptors
In force
 · Medium confidence
2SEVENTY Bio, Inc.In forceMedium confidence
US 12,291,722Improved Methods for Manufacturing Adoptive Cell Therapies
In force
 · High confidence
2SEVENTY Bio, Inc.In forceHigh confidence
US 10,479,975Methods of Making T Cell Compositions
In force
 · High confidence
2SEVENTY Bio, Inc.In forceHigh confidence
US 11,479,755T Cell Compositions
In force
 · High confidence
2SEVENTY Bio, Inc.In forceHigh confidence
US 12,644,099Methods for Making T Cell Compositions
In force
 · Medium confidence
2SEVENTY Bio, Inc.In forceMedium confidence
US 11,530,265Multipartite Signaling Proteins and Uses Thereof
In force
 · Medium confidence
Regeneron Pharmaceuticals, Inc.In forceMedium confidence
US 10,624,960Bcma Chimeric Antigen Receptors
In force
 · High confidence
2SEVENTY Bio, Inc.In forceHigh confidence
US 10,639,358Bcma Chimeric Antigen Receptors
In force
 · High confidence
2SEVENTY Bio, Inc.In forceHigh confidence
US 10,639,359Bcma Chimeric Antigen Receptors
In force
 · High confidence
2SEVENTY Bio, Inc.In forceHigh confidence
US 10,646,558Bcma Chimeric Antigen Receptors
In force
 · High confidence
2SEVENTY Bio, Inc.In forceHigh confidence
5 more term ends in 2035 · Pro
10 of 15 patents shown. Soonest term end first, then patent number.
Pro members see all 15.
Upgrade to Pro
14 of these are in force and held by 2SEVENTY Bio, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited